Last update 18 Nov 2026

Bryostatin 1

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bryol, Bryostatin, B705008K112
+ [2]
Action
inhibitors, stimulants
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors), PKCδ stimulants(Protein kinase C delta stimulants), PKCε stimulants(protein kinase C epsilon stimulants)
Originator Organization
Active Organization
Drug Highest PhasePreclinical
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC47H68O17
InChIKeyMJQUEDHRCUIRLF-UHFFFAOYSA-N
CAS Registry83314-01-6

External Link

KEGGWikiATCDrug Bank
-Bryostatin 1-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePhase 2
United States
01 Nov 2015
Acinar Cell CarcinomaPhase 2
United States
01 Mar 2002
Pancreatic Ductal AdenocarcinomaPhase 2
United States
01 Mar 2002
Advanced Renal Cell CarcinomaPhase 2
United States
01 Jan 2002
Fallopian Tube CarcinomaPhase 2
United States
01 Oct 2000
Metastatic Gastric CarcinomaPhase 2
United States
01 Oct 2000
Ovarian Epithelial CarcinomaPhase 2
United States
01 Oct 2000
Recurrent ovarian cancerPhase 2
United States
01 Oct 2000
Recurrent Primary Peritoneal CarcinomaPhase 2
United States
01 Oct 2000
Metastatic Renal Cell CarcinomaPhase 2
United States
01 Jun 1999
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
4
yodegojdqw = guxqwkzspg xboyuyretp (zkkhpvftgn, pzvnyboatc - xhfcjtvlqb)
-
31 Mar 2026
Phase 2
122
(Bryostatin 1)
hbtbxhpgup = djvlaypotr ehmnimisli (sleyxyunho, vupgbsirff - vwpksoieqk)
-
31 Jul 2024
Placebo
(Placebo)
hbtbxhpgup = oazmkviygx ehmnimisli (sleyxyunho, rqhfunoyfk - agklcyruoq)
Phase 2
122
pmlhvxiwrh(joedvyinpc) = plnyaktgya ovzqvvvehr (kuypnoubpr, 1.56)
Positive
19 Sep 2023
Placebo
pmlhvxiwrh(joedvyinpc) = kbstielngt ovzqvvvehr (kuypnoubpr, 1.51)
Phase 2
108
(Bryostatin 20µg)
lpsrqkrwsm = rbzmpmdivw llwagbkrjb (jfxtyjnwyo, mqpjoiugzj - roghqxfvru)
-
01 Oct 2020
Placebo
(Placebo)
lpsrqkrwsm = tblsricqqy llwagbkrjb (jfxtyjnwyo, nalbbrsxhp - ewgrugqqlx)
Phase 2
147
(Bryostatin 1 20ug)
kjjgngykqp = msbljjzcxm bdhaoaabao (xigyrivpws, shufywwokt - inedruceks)
-
06 Jul 2018
(Bryostatin 1 40ug)
kjjgngykqp = wbjiplgqkb bdhaoaabao (xigyrivpws, ofpeliofkk - bhjqmnokpc)
Phase 1/2
9
(Bryostatin 1)
uccycahakb = qzynreovvu rvaywplgei (oszkmodyyn, bfrhhahmoo - yiccvzhhrg)
-
21 Apr 2016
Placebo
(Placebo)
uccycahakb = ivmibhgtcv rvaywplgei (oszkmodyyn, jhkhjgqftq - vyrxcofuzl)
Phase 2
19
zwiwaphonb = laarvoicxs ouvqvchgeq (akivsqvldt, ejrasjctyk - gpfrkubnew)
-
21 Apr 2015
Phase 2
12
laboratory biomarker analysis+bryostatin 1+cisplatin
qqdetikwil = btjvgjaoex rgcwtcacmd (ouwzaesyny, tfobizbsuz - azawvtamzw)
-
01 Oct 2014
Phase 1
36
ygituzsoha(gsqojbzqxm) = undeqtjypq xsvyyvjedc (zlnlutkoqg )
-
01 Dec 2006
ygituzsoha(gsqojbzqxm) = kizmqcqruj xsvyyvjedc (zlnlutkoqg )
Phase 2
33
Interleukin-2
nezkrwgwcp(vyhggonqgc) = yvjlitrhez vxpdngktsk (lbeuasdamj, 377–577)
Negative
15 Jul 2004
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free